Skip to content
Log in
Sponsored Design Multi-Agent AI Systems Using MCP and A2A: Engineer your own Pyt Design Multi-Agent AI Systems Using MCP and A2A: Engineer your own Pyt

Effect of intranasal midazolam with/without inhalation sedation (N2O/O2) in 3‒6-year-old uncooperative dental patients

Unknown authors
· 0 citations · 1 references

TL;DR

To manage the behavior of the children with high levels of dental anxiety, the combination of inhalation sedation with intranasal midazolam can be efficiently used.

Semantic Scholar
View source

Similar papers

Open access 2026

Efficacy and safety of intranasal midazolam, S-ketamine, and dexmedetomidine as premedication for pediatric tonsillectomy: A comparative study (premedication in pediatric tonsillectomy study)

S-ketamine provides superior analgesia and reduces intraoperative opioid requirements without compromising sedation or anxiolysis, suggesting it may be a preferable option in this population of children undergoing tonsillectomy.

Ivana Fajertag, Vlado Janković, Maja Sujica et al. · 0 citations
Open access Jul 2026

The median effective dose (ED50) of remimazolam combined with esketamine for conscious sedation in patients with dental anxiety undergoing outpatient dental surgery: a prospective, dose-finding study.

The ED50 provides a preliminary reference for initial dose selection in this clinical setting and requires validation in larger studies, but the wide confidence interval of the ED95 limits its clinical utility and requires validation in larger studies.

Mengjiao Che, Cuiyao Kang, Cuiyun Zhou et al. · 0 citations
Open access Aug 2026

Effectiveness of Intranasal Dexmedetomidine for Sedation in Children.

Intranasal DEX at a dose of 1.5 mcg/kg is safe and effective premedication for paediatric patients, which results in successful sedation with tolerated changes in vitals, which was well tolerated.

Mona Sharma, Swagat Gongal, B. Yadav et al. · 0 citations
Open access Jul 2026

Comparison of intranasal ketamine versus intranasal dexmedetomidine as a pre-medication during induction of anesthesia in pediatric patients

Intranasal dexmedetomidine appears to be the preferred premedication for facilitating smooth anesthetic induction in pediatric patients undergoing elective surgery while maintaining comparable hemodynamic stability and induction time.

Arifa Sultan, Saeedah Asaf · 0 citations
Aug 2026

The efficacy of oral montelukast versus intranasal fluticasone furoate in reducing the severity of pediatric sleep-disordered breathing: A randomized clinical trial.

Fluticasone furoate may be appropriate for adenoid hypertrophy, while montelukast is favored for concurrent tonsillar hypertrophy, and these treatments may serve as alternatives to surgery in selected cases.

S. Rothman, Ronly Har-Even, Ofer Israel et al. · 0 citations
Open access Jul 2026

Sedative effects of administration through the nares of dexmedetomidine, midazolam, and butorphanol in cockatiels (Nymphicus hollandicus): a preliminary crossover study.

Findings indicate that administration through the nares dexmedetomidine at 0.06 or 0.08 mg/kg combined with midazolam and butorphanol provides deeper, more stable, and reversible sedation and improved control of stress responses in cockatiels and may represent a clinically useful protocol in this species.

Sakura Isayama, Mizuki Tanahashi, S. Doi et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.